These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9280543)
1. [Super radical surgery of advanced ovarian cancers (stages III and IV)]. Michel G; Castaigne D; Morice P; Lhommé C; Duviliard P Contracept Fertil Sex; 1997 Jun; 25(6):V-XI. PubMed ID: 9280543 [No Abstract] [Full Text] [Related]
2. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S; J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344 [TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. Vergote I; Tropé CG; Amant F; Kristensen GB; Ehlen T; Johnson N; Verheijen RH; van der Burg ME; Lacave AJ; Panici PB; Kenter GG; Casado A; Mendiola C; Coens C; Verleye L; Stuart GC; Pecorelli S; Reed NS; ; N Engl J Med; 2010 Sep; 363(10):943-53. PubMed ID: 20818904 [TBL] [Abstract][Full Text] [Related]
4. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277 [TBL] [Abstract][Full Text] [Related]
5. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up. Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777 [TBL] [Abstract][Full Text] [Related]
7. [Evolution and perspectives in the surgical treatment of ovarian cancer]. Cherenkov VG; Shpenkova AA Vopr Onkol; 2010; 56(4):450-5. PubMed ID: 20968025 [TBL] [Abstract][Full Text] [Related]
8. Carcinoma of the ovary. Heintz AP; Odicino F; Maisonneuve P; Beller U; Benedet JL; Creasman WT; Ngan HY; Sideri M; Pecorelli S J Epidemiol Biostat; 2001; 6(1):107-38. PubMed ID: 11385772 [No Abstract] [Full Text] [Related]
9. [Treatment outcomes for advanced ovarian cancers with peritoneal dissemination]. Oe S; Hasegawa K; Ichikawa R; Torii Y; Kato R; Komiyama S; Udagawa Y Gan To Kagaku Ryoho; 2011 Apr; 38(4):591-7. PubMed ID: 21498987 [TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery for stage IV epithelial ovarian cancer. Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968 [TBL] [Abstract][Full Text] [Related]
11. [Secondary cytoreductions in the treatment of ovarian cancers]. Zylberberg B; Dormont D; Janklewicz S; Daraï E; Madelenat P; Antoine JM Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587 [TBL] [Abstract][Full Text] [Related]
12. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer. Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972 [TBL] [Abstract][Full Text] [Related]
13. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy. Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397 [TBL] [Abstract][Full Text] [Related]
14. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer. Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445 [TBL] [Abstract][Full Text] [Related]
16. Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction. Sood AK; Sorosky JI; Gelder MS; Buller RE; Anderson B; Wilkinson EJ; Benda JA; Morgan LS Cancer; 1998 May; 82(9):1731-7. PubMed ID: 9576296 [TBL] [Abstract][Full Text] [Related]
17. [The impact of the pathologist on the treatment of epithelial ovarial cancer]. Zivanovic O; Braun M; Park TW; Kuhn W Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679 [TBL] [Abstract][Full Text] [Related]
18. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past? Skirnisdottir I; Nordqvist S; Sorbe B Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740 [TBL] [Abstract][Full Text] [Related]
19. [Current treatment of malignant epithelial tumors of the ovary]. Michel G; Castaigne D; Morice P Ann Chir; 1997; 51(10):1051-7. PubMed ID: 10868026 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]